Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2'-O-ribose methyltransferases.
The EMBO journal
View this publicationThe EMBO journal
View this publicationScience advances
View this publicationTherapeutic advances in musculoskeletal disease
View this publicationFrontiers in immunology
View this publicationJournal of immunotherapy (Hagerstown, Md. : 1997)
View this publicationThe Prostate
View this publicationThe British journal of dermatology
View this publicationPLoS neglected tropical diseases
View this publicationJournal of clinical medicine
View this publicationEuropean journal of nuclear medicine and molecular imaging
View this publication